Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Vaccines

Free Subscription 05.01.2026 1 AIDS 2 Clin Infect Dis 1 J Immunol 2 J Infect Dis 1 J Virol 3 JAMA 1 N Engl J Med 1 Nat Med 1 Pediatr Infect Dis J 4 PLoS One 2 Proc Natl Acad Sci U S A 31 Vaccine 1 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. WILLIAMS A, Adungo F, Ramirez JL, Oriol-Mathieu V, et al
   The role of subtyping methodologies in HIV surveillance and vaccine development: a systematic review and meta-analysis.
   AIDS. 2025 Dec 30. doi: 10.1097/QAD.0000000000004427.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. SHAHAR E
   Estimating Vaccine Effectiveness Against Symptomatic Infection From Its Effectiveness Against Asymptomatic Infection.
   Clin Infect Dis. 2025 Dec 31:ciaf735. doi: 10.1093.
   PubMed        
   
   
3. LAI SW, Chiu SC
   Herpes zoster, vaccine, and stroke risk.
   Clin Infect Dis. 2025 Dec 26:ciaf725. doi: 10.1093.
   PubMed        
   
   

   
   J Immunol

4. OSUAGWU AE, Payne M, Bosch J, Mbonye U, et al
   Non-neutralizing antibodies against SARS-CoV-2 nucleocapsid protein mediate variant transcendent antibody-dependent cellular cytotoxicity.
   J Immunol. 2025;214:3385-3398.
   PubMed         Abstract available
   
   

   
   J Infect Dis

5. SIERRA MS, Coto C, Porras C, Herrero R, et al
   Validation of TypeSeq2, a Next-Generation-Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories.
   J Infect Dis. 2025;232:e906-e915.
   PubMed         Abstract available
   
   
6. JONES JM, Grebe E, Lartey I, Stone M, et al
   Estimated US Trends in SARS-CoV-2 Spike Antibody Concentrations and Correlation to Risk of First-Time Infections Based on Blood Donations, 2022.
   J Infect Dis. 2025;232:1302-1308.
   PubMed         Abstract available
   
   

   
   J Virol

7. DIEGO JG-B, Arranz-Herrero J, Laghlali G, Burgess E, et al
   Disease modulation by TIV vaccination during secondary pneumococcal infections in influenza-infected mice.
   J Virol. 2025 Dec 29:e0177425. doi: 10.1128/jvi.01774.
   PubMed         Abstract available
   
   

   
   JAMA

8. JABAGI MJ, Bertrand M, Gabet A, Kolla E, et al
   Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns.
   JAMA. 2025 Dec 22:e2524082. doi: 10.1001/jama.2025.24082.
   PubMed         Abstract available
   
   
9. ANDERER S
   AAP Continues Recommending Birth Dose of Hepatitis B Vaccine After ACIP's Vote to Remove.
   JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23003.
   PubMed        
   
   
10. ANDERER S
    PAHO Urges Vaccination as Whooping Cough Surges in the Americas.
    JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23006.
    PubMed        
    
    

    
    N Engl J Med

11. 
    Live Attenuated Varicella Virus Vaccine - Efficacy Trial in Healthy Children.
    N Engl J Med. 2025 Dec 19. doi: 10.1056/NEJMx250021.
    PubMed        
    
    

    
    Nat Med

12. SIMONS D, Watson-Jones D, Manno D, Friant S, et al
    A One Health trial design to accelerate Lassa fever vaccines.
    Nat Med. 2026 Jan 2. doi: 10.1038/s41591-025-04018.
    PubMed        
    
    

    
    Pediatr Infect Dis J

13. HOMAIRA N, Qian J, Scaria A, Stepien S, et al
    Effectiveness of Maternal Influenza Vaccination on Influenza and Acute Respiratory Infection in Infants.
    Pediatr Infect Dis J. 2025 Dec 23. doi: 10.1097/INF.0000000000005111.
    PubMed         Abstract available
    
    

    
    PLoS One

14. BHATTACHARYA A, Mark-Uchendu C, Hansen C, Evans J, et al
    Systematic review of mHealth and digital health interventions to improve childhood vaccination uptake in 19 Sub-Saharan African countries.
    PLoS One. 2025;20:e0324117.
    PubMed         Abstract available
    
    
15. ALOTAIBI BS, Khan F, Rehmani MBI, Arshad F, et al
    In-silico core proteome analysis for chimeric vaccine development against tick-borne tularemia.
    PLoS One. 2025;20:e0337692.
    PubMed         Abstract available
    
    
16. LEE J, Park J, La TM, Hyeon JY, et al
    Genomic insights into the expansion of meropenem-resistant GPSC1-CC320 Streptococcus pneumoniae serotype 19A isolates from children under 5 years of age with invasive infections, 2018-2024.
    PLoS One. 2025;20:e0325870.
    PubMed         Abstract available
    
    
17. AZIZ K, Ismail MS, Bibars M, Selim N, et al
    Attitude, self-efficacy, and perceived risk toward seasonal influenza vaccination among primary care physicians in Qatar: A cross-sectional study.
    PLoS One. 2026;21:e0323518.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

18. GLEASON A, Impalli I, Sheen J, Cabezas Murillo A, et al
    Global vaccination coverage and disease incidence in cattle, pigs, and poultry.
    Proc Natl Acad Sci U S A. 2025;122:e2515557122.
    PubMed         Abstract available
    
    
19. WIATR M, Wang Z, Canis M, Hernandez B, et al
    Memory B cell development in response to mRNA SARS-CoV-2 and nanoparticle immunization in mice.
    Proc Natl Acad Sci U S A. 2026;123:e2527869123.
    PubMed         Abstract available
    
    

    
    Vaccine

20. NGOCHO JS, van der Gaast-de Jongh CE, Sebba J, Mtei M, et al
    Emergence of non-vaccine Streptococcus pneumoniae serotypes colonizing the nasopharynx of children under five years of age in the 13-valent pneumococcal conjugate vaccine era in Tanzania. A short communication.
    Vaccine. 2025;61:127336.
    PubMed         Abstract available
    
    
21. NGOCHO JS, van der Gaast de Jongh CE, Sebba J, Mtei M, et al
    Corrigendum to "Emergence of non-vaccine Streptococcus pneumoniae serotypes colonizing the nasopharynx of children under the age of five years in the 13-valent pneumococcal conjugate vaccine era in Tanzania. A short communication" [Vaccine 48 (2025) 1
    Vaccine. 2025;61:127335.
    PubMed        
    
    
22. BREZNIK JA, Ang JC, Bhakta H, Liu LM, et al
    Humoral and cellular immunogenicity of sequential heterogeneous bivalent SARS-CoV-2 vaccinations in long-term care and retirement home residents.
    Vaccine. 2025;73:128160.
    PubMed         Abstract available
    
    
23. OKABE H, Hashimoto K, Asano Y, Sato M, et al
    Adverse events post-BNT162b2 vaccination in Japanese children.
    Vaccine. 2025;73:128167.
    PubMed         Abstract available
    
    
24. JANG AY, Ji HJ, Kang EH, Choi YJ, et al
    Cross-reactive immunity within pneumococcal serogroups: Implications for next-generation vaccine development.
    Vaccine. 2025;73:128179.
    PubMed         Abstract available
    
    
25. DANIEL N, Smith C, Miah N, Akroyd C, et al
    Enablers and barriers to participation in vaccine trials: a narrative synthesis.
    Vaccine. 2025;73:128183.
    PubMed         Abstract available
    
    
26. JAMISON AM, Gardner LM
    What happens when the CDC stops posting about measles on social media? An exploratory analysis of social media coverage during the 2025 measles outbreak.
    Vaccine. 2026;71:128074.
    PubMed         Abstract available
    
    
27. HARO SLY MJ, Zubeldia L
    COVID-19 vaccine production and the technological gap in the Global South: The cases of Argentina and Brazil.
    Vaccine. 2025;72:128141.
    PubMed         Abstract available
    
    
28. PHADKE VK, Bednarczyk RA, Maldonado H, McCracken JP, et al
    Impact of pregnancy on longitudinal pertussis antibody responses to Tdap vaccine in Guatemala.
    Vaccine. 2025;72:128134.
    PubMed         Abstract available
    
    
29. KOVACS D, Brar G, Anthony SJ, Wang LF, et al
    Initiation of a coronavirus vaccine library.
    Vaccine. 2025;72:128140.
    PubMed         Abstract available
    
    
30. MA W, Yu Y, Zhu N, Zhang F, et al
    Ensuring structural integrity of Hib capsular polysaccharide in conjugate vaccine manufacturing by (1)H NMR and HPSEC-MALLS/RI.
    Vaccine. 2025;72:128145.
    PubMed         Abstract available
    
    
31. BARRY EVH, Suffel AM, Walker J, Andrews N, et al
    Disparities in uptake of Shingrix(R) vaccine in immunosuppressed individuals in England: a population-based cohort study.
    Vaccine. 2025;72:128078.
    PubMed         Abstract available
    
    
32. RAMAKRISHNAN SM, Ganaie FA, Govindan V, Mavupadi AM, et al
    Pneumococcal baseline IgG antibody levels and immune response to 23-valent pneumococcal polysaccharide vaccine among Indian adults.
    Vaccine. 2025;73:128157.
    PubMed         Abstract available
    
    
33. SEESKIN ZH, Steffan M, Geistwhite B, Yarbrough M, et al
    Using latent class analysis of survey data to explore parent behaviors and attitudes regarding children's COVID vaccinations.
    Vaccine. 2025;73:128149.
    PubMed         Abstract available
    
    
34. LARSEN FD, Juhl AK, Dietz LL, Nielsen H, et al
    Immunogenicity of SARS-CoV-2 primary vaccination and boosters in patients with immune-mediated inflammatory diseases: Impact of immunosuppressive therapy.
    Vaccine. 2025;73:128155.
    PubMed         Abstract available
    
    
35. ZHANG G, Li W, Sui X, Guo Y, et al
    Characterization and vaccine-induced immunogenicity of a re-emerging Neisseria meningitidis serogroup Y in Tianjin, China.
    Vaccine. 2025;73:128156.
    PubMed         Abstract available
    
    
36. PAL SS, Kim KH, Bhatnagar N, Grovenstein P, et al
    A combination of new prefusion mRNA and protein vaccines enhances neutralizing antibodies and protection against respiratory syncytial virus.
    Vaccine. 2025;73:128154.
    PubMed         Abstract available
    
    
37. STOUT NL, Rudisill TM, Halbritter K, Ahmed H, et al
    Developing an implementation plan to improve vaccine uptake in pulmonary medicine: An institutional approach through the American Thoracic Society vaccine initiative.
    Vaccine. 2025;73:128138.
    PubMed         Abstract available
    
    
38. SALLOUM M, Vandermosten L, Maseko T, Milolo S, et al
    Assessing vaccination coverage and antibody levels for measles, pertussis, and tetanus in Boende, DR Congo: Implications for maternal and child health.
    Vaccine. 2025;73:128083.
    PubMed         Abstract available
    
    
39. ALVES K, Kouassi A, Nelson J, Plested JS, et al
    Safety and immunogenicity of a single dose of a JN.1 variant COVID-19 vaccine in previously vaccinated adults: Primary analysis report of a phase 3 open-label trial.
    Vaccine. 2025;73:128164.
    PubMed         Abstract available
    
    
40. ZHAO D, Chen G, Wang S, Suo Y, et al
    A single ultra-low dose self-amplifying RNA rabies vaccine confers rapid and complete protection in mice.
    Vaccine. 2025;73:128150.
    PubMed         Abstract available
    
    
41. TECHAWIWATTANABOON T, Leekitcharoenphon R, Alameh MG, Boonkea S, et al
    mRNA vaccines targeting Leptospira immunoglobulin-like proteins confer partial protection in a hamster model of leptospirosis.
    Vaccine. 2025;73:128099.
    PubMed         Abstract available
    
    
42. FEBRIANI Y, Ursu MM, Sauvageau C, Kegbevi KB, et al
    Immune memory assessment three years following a single dose of hepatitis a vaccine at 12, 13 or 19 months of age.
    Vaccine. 2025;73:128144.
    PubMed         Abstract available
    
    
43. HUNT AR, Regan AK, Perkins RB, Wise LA, et al
    The effect of human papillomavirus vaccination during adolescence or early adulthood on incidence of spontaneous abortion in adulthood.
    Vaccine. 2025;72:128152.
    PubMed         Abstract available
    
    
44. DROBIC B, Akintunde G, Kim J, Mirceta M, et al
    Effect of Co-administration of the anthrax vaccine adsorbed, adjuvanted with ciprofloxacin or doxycycline on antibiotic pharmacokinetics and the vaccine immunogenicity: A phase 2 drug-vaccine interaction study.
    Vaccine. 2025;73:128135.
    PubMed         Abstract available
    
    
45. MIRON E, Sauvageau C, Dube E, Vivion M, et al
    Vaccine hesitancy among older adults, urban indigenous and newcomers in Canada: A qualitative comparative study.
    Vaccine. 2025;73:128143.
    PubMed         Abstract available
    
    
46. PINANDYO SH, Ali S, Aurelio B, Amoah AS, et al
    The association of helminth infection against antimalarial antibody responses in malaria infection and vaccination: a systematic review and meta-analysis.
    Vaccine. 2025;73:128125.
    PubMed         Abstract available
    
    
47. STRENG BMM, Hensen LCM, Delemarre EM, Binnendijk RS, et al
    Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndrome.
    Vaccine. 2025;73:128079.
    PubMed         Abstract available
    
    
48. PIJPERS J, van Roon A, van den Hof S, van Gaalen R, et al
    Large differences in MMR and DTaP-IPV vaccination coverage among primary schools by denomination, the Netherlands, 2024.
    Vaccine. 2025;72:128137.
    PubMed         Abstract available
    
    
49. NONBOE MH, Napolitano G, Schroll JB, Andersen B, et al
    Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2+ from childhood vaccinated women: The Trial23 cohort study.
    Vaccine. 2025;73:128142.
    PubMed         Abstract available
    
    
50. BOUM Y, Ibeneme CU, Nsasiirwe S, Nakame R, et al
    Mpox vaccines: an urgent equity imperative.
    Vaccine. 2025;73:128158.
    PubMed        
    
    

    
    Virology

51. NGUYEN CT, Nakayama M, Yasui F, Ishigaki H, et al
    Vaccinia virus-based SARS-CoV-2 vaccine prevents lung immunopathology without antibody-dependent enhancement in female rhesus macaques.
    Virology. 2025;616:110778.
    PubMed         Abstract available
    
    

    
    Virus Res

52. KWAN E, Legione AR, Hartley CA, Devlin JM, et al
    Transcriptomic analysis of Crandell-Rees feline kidney cell infections with field and vaccine feline calicivirus strains.
    Virus Res. 2025 Dec 21:199681. doi: 10.1016/j.virusres.2025.199681.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.